ThÃ©rapie gÃ©nique chez les 5 Ã 11 ans : quels sont les risques ?

lababouche
Published on Nov 30, 2021
Nicolas Derome (PhD), professeur titulaire au dÃ©partement de biologie de lâ€™UniversitÃ© Laval, apporte des informations importantes, afin de faire un choix libre et Ã©clairÃ© Ã ce sujet. Est-ce utile ? RecommandÃ© ? LÃ©gal, Ã©thique ?
Faites circuler massivement Ã tous les parents qui se trouvent actuellement dans une position dÃ©licate au sujet de leurs enfants.
RÃ©info Covid QuÃ©bec prÃ©pare actuellement une confÃ©rence de presse choc avec des spÃ©cialistes du mÃªme calibre, afin dâ€™avoir une information de qualitÃ© sur ces questions qui touche ce que nous avons de plus prÃ©cieux dans notre sociÃ©tÃ© : les enfants !
Si vous Ãªtes scientifique, universitaire, chercheur et dÃ©sirez vous joindre Ã nous, rendez-vous sur notre site : www.reinfocovid.ca
RÃ‰FÃ‰RENCES DE CETTE PRÃ‰SENTATION :
(1) Ledford, Heidi. â€œDeaths from COVID 'incredibly rare' among children.â€ Nature vol. 595,7869 (2021): 639.
(2) Wu & McGoogan. 2020. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72â€¯314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 February 24
(3) CDC COVID-19 Response Team. Coronavirus disease 2019 in childrenâ€”United States, February 12â€“April 2, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(14):422-426.
(4) Gudbjartsson DF, et al. Spread of SARS-CoV-2 in the Icelandic population. N Engl J Med 2020:NEJMoa2006100.
(5) Lavezzo E, et al. Suppression of COVID-19 outbreak in the municipality of Vo, Italy. medRxiv 2020 [preprint]. doi:10.1101/2020.04.17.20 053157.
(6) Lu X, et al. SARS-CoV-2 infection in children. N Engl J Med 2020:NEJMc2005073. doi:10.1056/NEJMc2005073.
(7) Jing et al. Household secondary attack rate of COVID-19 and associated determinants. medRxiv 2020 [preprint]. doi:10.1101/2020.04.11.20056010.
(8) National Centre for Immunisation and SurveillanceCOVID-19 in schools â€“ the experience in NSW, 2020. http:// ncirs.org.au
(9) The National Institute for Public Health and the Environment (RVIM).Children and COVID-19, 2020. https://www. rivm. nl/ en/ novel- coronaviruscovid-19/ children- and- covid- 19
10) Weisberg, Stuart P et al. â€œDistinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum.â€ Nature immunology vol. 22,1 (2021): 25-31.
(11) Pierce, C. A. et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci. Transl. Med. 12, eabd5487 (2020).
(12) Gruber, C. N. et al. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell https://doi.org/10.1016/j.cell.2020.0... (2020).
(13) Singanayagam et al. 2021. â€œCommunity transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study.â€ The Lancet. Infectious diseases, S1473-3099(21)00648-4.